1-8 of 8
Brian Booth
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

FDA Approval Summary: Olutasidenib for Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase 1 Mutation

Ashley C. Woods, Kelly J. Norsworthy, Moran Choe, Brenda J. Gehrke, Haiyan Chen, Jonathon Vallejo, Lili Pan, Xiling Jiang, Hongshan Li, Jeffrey Kraft, Jiang Liu, Rosane Charlab, Olanrewaju O. Okusanya, Brian Booth, Richard Pazdur, Marc R. Theoret, R. Angelo de Claro
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (1): 12–17.
https://doi.org/10.1158/1078-0432.CCR-24-2196
Published: 06 January 2025
View article titled, FDA Approval Summary: Olutasidenib for Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an <em>Isocitrate Dehydrogenase 1</em> Mutation
Open the PDF for FDA Approval Summary: Olutasidenib for Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an <em>Isocitrate Dehydrogenase 1</em> Mutation in another window
Includes: Supplementary data
Journal Articles

Vandetanib for the Treatment of Symptomatic or Progressive Medullary Thyroid Cancer in Patients with Unresectable Locally Advanced or Metastatic Disease: U.S. Food and Drug Administration Drug Approval Summary

Katherine Thornton, Geoffrey Kim, V. Ellen Maher, Somesh Chattopadhyay, Shenghui Tang, Young Jin Moon, Pengfei Song, Anshu Marathe, Suchitra Balakrishnan, Hao Zhu, Christine Garnett, Qi Liu, Brian Booth, Brenda Gehrke, Robert Dorsam, Leigh Verbois, Debasis Ghosh, Wendy Wilson, John Duan, Haripada Sarker, Sarah Pope Miksinski, Lisa Skarupa, Amna Ibrahim, Robert Justice, Anthony Murgo, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (14): 3722–3730.
https://doi.org/10.1158/1078-0432.CCR-12-0411
Published: 15 July 2012
View article titled, Vandetanib for the Treatment of Symptomatic or Progressive Medullary Thyroid Cancer in Patients with Unresectable Locally Advanced or Metastatic Disease: U.S. Food and Drug Administration Drug Approval Summary
Open the PDF for Vandetanib for the Treatment of Symptomatic or Progressive Medullary Thyroid Cancer in Patients with Unresectable Locally Advanced or Metastatic Disease: U.S. Food and Drug Administration Drug Approval Summary in another window
Journal Articles

Tasigna for Chronic and Accelerated Phase Philadelphia Chromosome–Positive Chronic Myelogenous Leukemia Resistant to or Intolerant of Imatinib

Maitreyee Hazarika, Xiaoping Jiang, Qi Liu, Shwu-Luan Lee, Roshni Ramchandani, Christine Garnett, Micheal S. Orr, Rajeshwari Sridhara, Brian Booth, John K. Leighton, William Timmer, Ravi Harapanhalli, Ramzi Dagher, Robert Justice, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (17): 5325–5331.
https://doi.org/10.1158/1078-0432.CCR-08-0308
Published: 02 September 2008
View article titled, Tasigna for Chronic and Accelerated Phase Philadelphia Chromosome–Positive Chronic Myelogenous Leukemia Resistant to or Intolerant of Imatinib
Open the PDF for Tasigna for Chronic and Accelerated Phase Philadelphia Chromosome–Positive Chronic Myelogenous Leukemia Resistant to or Intolerant of Imatinib in another window
Journal Articles

Ixabepilone in Combination with Capecitabine and as Monotherapy for Treatment of Advanced Breast Cancer Refractory to Previous Chemotherapies

Robert J. Lechleider, Edvardas Kaminskas, Xiaoping Jiang, Robeena Aziz, Julie Bullock, Ravindra Kasliwal, Ravi Harapanhalli, Sarah Pope, Rajeshwari Sridhara, John Leighton, Brian Booth, Ramzi Dagher, Robert Justice, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (14): 4378–4384.
https://doi.org/10.1158/1078-0432.CCR-08-0015
Published: 15 July 2008
View article titled, Ixabepilone in Combination with Capecitabine and as Monotherapy for Treatment of Advanced Breast Cancer Refractory to Previous Chemotherapies
Open the PDF for Ixabepilone in Combination with Capecitabine and as Monotherapy for Treatment of Advanced Breast Cancer Refractory to Previous Chemotherapies in another window
Journal Articles

Sprycel for Chronic Myeloid Leukemia and Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia Resistant to or Intolerant of Imatinib Mesylate

Michael Brave, Vicki Goodman, Edvardas Kaminskas, Ann Farrell, William Timmer, Sarah Pope, Ravi Harapanhalli, Haleh Saber, David Morse, Julie Bullock, Angela Men, Carol Noory, Roshni Ramchandani, Leslie Kenna, Brian Booth, Joga Gobburu, Xiaoping Jiang, Rajeshwari Sridhara, Robert Justice, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (2): 352–359.
https://doi.org/10.1158/1078-0432.CCR-07-4175
Published: 25 January 2008
View article titled, Sprycel for Chronic Myeloid Leukemia and Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia Resistant to or Intolerant of Imatinib Mesylate
Open the PDF for Sprycel for Chronic Myeloid Leukemia and Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia Resistant to or Intolerant of Imatinib Mesylate in another window
Journal Articles

Sorafenib for the Treatment of Advanced Renal Cell Carcinoma

Robert C. Kane, Ann T. Farrell, Haleh Saber, Shenghui Tang, Gene Williams, Josephine M. Jee, Chengyi Liang, Brian Booth, Nallaperumal Chidambaram, David Morse, Rajeshwari Sridhara, Patricia Garvey, Robert Justice, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (24): 7271–7278.
https://doi.org/10.1158/1078-0432.CCR-06-1249
Published: 22 December 2006
View article titled, Sorafenib for the Treatment of Advanced Renal Cell Carcinoma
Open the PDF for Sorafenib for the Treatment of Advanced Renal Cell Carcinoma in another window
Journal Articles

Approval Summary for Erlotinib for Treatment of Patients with Locally Advanced or Metastatic Non–Small Cell Lung Cancer after Failure of at Least One Prior Chemotherapy Regimen

John R. Johnson, Martin Cohen, Rajeshwari Sridhara, Yeh-Fong Chen, Gene M. Williams, John Duan, Jogarao Gobburu, Brian Booth, Kimberly Benson, John Leighton, Li Shan Hsieh, Nallalerumal Chidambaram, Paul Zimmerman, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (18): 6414–6421.
https://doi.org/10.1158/1078-0432.CCR-05-0790
Published: 15 September 2005
View article titled, Approval Summary for Erlotinib for Treatment of Patients with Locally Advanced or Metastatic Non–Small Cell Lung Cancer after Failure of at Least One Prior Chemotherapy Regimen
Open the PDF for Approval Summary for Erlotinib for Treatment of Patients with Locally Advanced or Metastatic Non–Small Cell Lung Cancer after Failure of at Least One Prior Chemotherapy Regimen in another window
Journal Articles

Approval Summary for Zoledronic Acid for Treatment of Multiple Myeloma and Cancer Bone Metastases

Amna Ibrahim, Nancy Scher, Grant Williams, Rajeshwari Sridhara, Ning Li, Gang Chen, John Leighton, Brian Booth, Jogarao V. S. Gobburu, Atiqur Rahman, Yung Hsieh, Rebecca Wood, Debra Vause, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (7): 2394–2399.
Published: 01 July 2003
View article titled, Approval Summary for Zoledronic Acid for Treatment of Multiple Myeloma and Cancer Bone Metastases
Open the PDF for Approval Summary for Zoledronic Acid for Treatment of Multiple Myeloma and Cancer Bone Metastases in another window